Procyrion, Inc.
Circulatory support to the cath-lab. New and Young
3900 Essex Lane
Suite 250
Houston, TX 77027
United States
Founded in 2005


Bringing long-term circulatory support to the cath-lab with a novel, intra-aortic pump that can be deployed and retrieved via catheter.

Total Funding: $18.7m
Founded: 2005, Headcount: 9
Procyrion, Inc. develops and manufactures ventricular assist device (CVAD) that restores hemodynamics through continuous aortic flow augmentation. The ventricular assist device is deployed percutaneously within the descending aorta and held axiosymmetric within the aorta by a self-expanding strut fixation system. Once the pump is activated, a micro-motor and impeller pulls fluid from the heart and restores body hemodynamics. The pump can then be retrieved through a catheter-based procedure when the heart has had a chance to heal. Procyrion, Inc. was founded in 2005 and is based in Houston, Texas.
Key Executives For Procyrion, Inc.
Dr. Benjamin A. Hertzog Ph.D.

Chief Executive Officer and President
Dr. Reynolds Delgado M.D.Founder
Compensation as of Fiscal Year 2016.
Procyrion announced that Gary Burbach will be joining its board of directors. Burbach currently serves as a director or advisor to multiple private, venture-backed and public life science companies. From 2006 to 2014, Mr. Burbach served as president, chief executive officer, and director of Thoratec Corporation. Burbach currently serves on the boards of Fluidigm Corporation and Autonomic Technologies and also supports Titan Spine and Microfabrica as an executive advisor.